证券记录 · 已归档季度
COGT
Cogent Biosciences, Inc. · Healthcare · Biotechnology
20被追踪持有人
+4Δ持有人
59.75M持有股份
$857.99M报告持仓市值
+4新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +25.0% ·
股份流向 +22.8% ·
净新建仓位 +20.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 1.18M | $37.86M | n/a | −1 |
| Q2 2026 | 103 | +4 | 108.45M | $4.20B | +7 | −4 |
| Q1 2026 | 103 | +9 | 108.14M | $4.02B | +15 | −6 |
| Q4 2025 | 92 | +1 | 96.22M | $3.42B | +1 | n/a |
| Q3 2025 | 20 | +4 | 59.75M | $857.99M | +4 | n/a |
| Q2 2025 | 13 | -2 | 45.58M | $327.23M | n/a | −2 |
| Q1 2025 | 12 | -1 | 13.98M | $83.77M | n/a | −1 |
| Q4 2024 | 13 | 0 | 17.19M | $134.06M | +1 | −1 |
| Q3 2024 | 12 | +2 | 19.61M | $211.75M | +2 | n/a |
| Q2 2024 | 10 | n/a | 18.90M | $159.29M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 22.41M | +31.2% | $321.78M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 2 | BlackRock ✦ (被动) | 10.37M | +20.2% | $148.91M | 0.0% | ▲ Add | 2 | SEC ↗ ×10 |
| 3 | The Vanguard Group ✦ (被动) | 7.76M | +18.9% | $111.40M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (被动) | 4.78M | +41.6% | $68.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 3.27M | +22.5% | $47.03M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 1.67M | +168.5% | $23.95M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 1.66M | n/a | $23.83M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 1.53M | +459.7% | $21.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 1.29M | n/a | $18.50M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 10 | Point72 Asset Management ✦ | 1.24M | -74.8% | $17.78M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Duquesne Family Office ✦ | 1.06M | 新增 | $15.22M | 0.4% | New | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 642.48K | 新增 | $9.23M | 0.0% | New | 1 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 562.00K | 新增 | $8.07M | 0.0% | New | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 414.97K | -57.2% | $5.96M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Wellington Management ✦ | 406.90K | +36.8% | $5.84M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 16 | Renaissance Technologies ✦ | 232.97K | 新增 | $3.35M | 0.0% | New | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 149.62K | n/a | $2.15M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 18 | AQR Capital Management ✦ | 116.84K | +159.2% | $1.68M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 19 | Fisher Asset Management ✦ | 103.49K | -6.7% | $1.49M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 89.72K | +22.6% | $1.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Duquesne Family Office | $15.22M | 0.4% |
| Marshall Wace | $9.23M | 0.0% |
| Adage Capital Partners | $8.07M | 0.0% |
| Renaissance Technologies | $3.35M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 304 持有人, 186.07M 股份, $6.90B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 27
Morris Arlene
Director · 42.35K 股 · $1.57M
Aug 27
Morris Arlene
Director · 3.16K 股 · $118,663
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A: Flynn James E
Jul 31
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
Jul 27
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据